Pharmacological characterization of glycine-activated currents in HEK 293 cells expressing N-methyl-D-aspartate NR1 and NR3 subunits
about
Enhanced ethanol inhibition of recombinant N-methyl-D-aspartate receptors by magnesium: role of NR3A subunitsMolecular mechanism of ligand recognition by NR3 subtype glutamate receptorsGlutamate receptor ion channels: structure, regulation, and functionClinical pharmacology of analgesics assessed with human experimental pain models: bridging basic and clinical research.Rules of engagement for NMDA receptor subunits.The Concise Guide to PHARMACOLOGY 2013/14: ligand-gated ion channels.Mechanisms underlying differential effectiveness of memantine and ketamine in rapid antidepressant responses.Expression of anaesthetic and analgesic drug target genes in excised breast tumour tissue: Association with clinical disease recurrence or metastasisInfluence of the NR3A subunit on NMDA receptor functions.Stoichiometry of N-methyl-D-aspartate receptors within the suprachiasmatic nucleus.Ligands for ionotropic glutamate receptorsStructure-based discovery of antagonists for GluN3-containing N-methyl-D-aspartate receptors.D-Serine and D-Cycloserine Reduce Compulsive Alcohol Intake in RatsModulation of NMDA receptor properties and synaptic transmission by the NR3A subunit in mouse hippocampal and cerebrocortical neuronsDephosphorylation of GluN2B C-terminal tyrosine residues does not contribute to acute ethanol inhibition of recombinant NMDA receptorsRole of major NMDA or AMPA receptor subunits in MK-801 potentiation of ethanol intoxicationClassifying neuronal subclasses of the cerebellum through constellation pharmacology.Expression of the N-methyl-D-aspartate receptor subunit NR3B regulates dendrite morphogenesis in spinal motor neurons.Assembly and forward trafficking of NMDA receptors (Review).Abused inhalants enhance GABA-mediated synaptic inhibition.Expression of glycine-activated diheteromeric NR1/NR3 receptors in human embryonic kidney 293 cells Is NR1 splice variant-dependent.NMDA Receptors in Glial Cells: Pending Questions.Glutamate receptors in the kidney.Do specific NMDA receptor subunits act as gateways for addictive behaviors?The kynurenine pathway and the brain: Challenges, controversies and promises.N-methyl-D-aspartate receptors in human erythroid precursor cells and in circulating red blood cells contribute to the intracellular calcium regulation.Excitatory glycine responses of CNS myelin mediated by NR1/NR3 "NMDA" receptor subunits.Residues in the GluN1 C-terminal domain control kinetics and pharmacology of GluN1/GluN3A N-methyl-d-aspartate receptors.Effects of ethanol on phosphorylation site mutants of recombinant N-methyl-D-aspartate receptors.Altered development of glutamatergic synapses in layer V pyramidal neurons in NR3A knockout mice.NMDA Receptors in the Central Nervous System.Properties of Triheteromeric N-Methyl-d-Aspartate Receptors Containing Two Distinct GluN1 Isoforms.Unmasking GluN1/GluN3A excitatory glycine NMDA receptors
P2860
Q24336440-9127D9B3-EA61-443D-997E-62276C3B63E8Q27651229-79F9B814-BED2-4C5F-939A-F0E90C96EDCBQ28290774-D8350118-4EA2-4E75-92C8-E049426036B4Q30443497-B1633CB0-81FD-4E0C-9059-A3D35294EF00Q30483647-3FA39ED4-FB87-4A7D-8538-540D9F9B3667Q30486732-973E1827-4677-424B-B06C-9089D4190E87Q30580921-049985D7-0665-4945-BE39-C84E7E8ED042Q33739171-35EADACC-19FF-4F58-8C1C-B063E8523218Q33906149-F32CD4D9-4896-4256-92B8-0A088B6CC204Q33923662-8E874B87-3F35-4DEC-B871-DF921DF7026EQ33980883-C2F836DB-2324-4078-A600-3798642EDB51Q34968786-C86A7428-4678-457A-8F2A-2650F88B866FQ35960341-C58BB88A-658D-4086-AD55-8DA9C961A62CQ36101234-4075FE2C-5A6B-4835-BDE1-94F80B1E0B23Q36741688-6DC846D5-172F-441A-8CF3-6D671373D3B1Q36922887-1E3BCFDB-7861-424D-80A1-D7D565896101Q36956308-1F17EBA7-3CD3-40DD-9FA6-500FC486C9F0Q37003724-3109F89C-3A6A-4B13-8491-BDBBE70351F7Q37150922-11BE2228-1451-4F75-8872-CE0D449A4D37Q37305239-408CAFF8-F5A0-4439-BBCF-9FDCEC0F7DA1Q37444406-7A9FE183-73FA-46CA-AA5D-B789A224FFFEQ38157889-EC0BDA25-BE27-4D7E-ABA9-8EB54479877EQ38398618-323E3DC2-6D61-441D-82CB-E404E7A48C9EQ38814541-02B9F309-6F6C-4C46-8009-729951917C78Q38832497-AB88688E-CBCF-4406-93CB-894402DBD3B4Q39094282-5C9D6196-591C-47AC-BBB9-5F2BEBBE2F2DQ39663368-270FFCCD-B393-41DC-8BE0-2184523277E9Q41106361-6D940D79-C773-46B3-BE51-E89CCA901D20Q41852173-BD8E859B-00E4-40F6-AC97-0FED0131A2E8Q42136733-3D8A929F-D67A-4CCE-B738-1651849AF1DBQ48029905-45E37B24-8B67-41DF-A9BE-111880D39205Q52684491-1A73B1B7-7B24-4298-A077-3EF81F65CA4BQ59137918-5E254789-79F4-47CE-B3BD-1C7AF9775CA8
P2860
Pharmacological characterization of glycine-activated currents in HEK 293 cells expressing N-methyl-D-aspartate NR1 and NR3 subunits
description
2007 nî lūn-bûn
@nan
2007 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Pharmacological characterizati ...... aspartate NR1 and NR3 subunits
@ast
Pharmacological characterizati ...... aspartate NR1 and NR3 subunits
@en
Pharmacological characterizati ...... aspartate NR1 and NR3 subunits
@en-gb
Pharmacological characterizati ...... aspartate NR1 and NR3 subunits
@nl
type
label
Pharmacological characterizati ...... aspartate NR1 and NR3 subunits
@ast
Pharmacological characterizati ...... aspartate NR1 and NR3 subunits
@en
Pharmacological characterizati ...... aspartate NR1 and NR3 subunits
@en-gb
Pharmacological characterizati ...... aspartate NR1 and NR3 subunits
@nl
prefLabel
Pharmacological characterizati ...... aspartate NR1 and NR3 subunits
@ast
Pharmacological characterizati ...... aspartate NR1 and NR3 subunits
@en
Pharmacological characterizati ...... aspartate NR1 and NR3 subunits
@en-gb
Pharmacological characterizati ...... aspartate NR1 and NR3 subunits
@nl
P921
P356
P1476
Pharmacological characterizati ...... aspartate NR1 and NR3 subunits
@en
P2093
C Thetford Smothers
John J Woodward
P304
P356
10.1124/JPET.107.123836
P407
P577
2007-08-01T00:00:00Z